Induction and Long-term Follow-up With ABX464 for Moderate-to-severe Ulcerative Colitis: Results of Phase IIa Trial.

Autor: Vermeire S; Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. Electronic address: Severine.Vermeire@uzleuven.be., Hébuterne X; Department of Gastroenterology and Clinical Nutrition, CHU of Nice, University Côte d'Azur, Nice, France., Tilg H; Department of Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University Innsbruck, Innsbruck, Austria., De Hertogh G; Department of Pathology, University Hospitals Leuven, Leuven, Belgium; Abivax, Paris, France., Gineste P; Department of Pathology, University Hospitals Leuven, Leuven, Belgium; Abivax, Paris, France., Steens JM; Department of Pathology, University Hospitals Leuven, Leuven, Belgium; Abivax, Paris, France.
Jazyk: angličtina
Zdroj: Gastroenterology [Gastroenterology] 2021 Jun; Vol. 160 (7), pp. 2595-2598.e3. Date of Electronic Publication: 2021 Mar 02.
DOI: 10.1053/j.gastro.2021.02.054
Databáze: MEDLINE